MarketBeat Instant News Alerts 2 hours agoMeta Platforms' (META) "Buy (B)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reissued a "buy (b)" rating on shares of Meta Platforms in a report on Saturday.NASDAQ:METARead Meta Platforms' (META) "Buy (B)" Rating Reiterated at Weiss Ratings2 hours agoAO World (LON:AO) Share Price Passes Above Fifty Day Moving Average on Insider SellingMarketBeatAO World (LON:AO) Stock Price Passes Above Fifty Day Moving Average on Insider SellingLON:AORead AO World (LON:AO) Share Price Passes Above Fifty Day Moving Average on Insider Selling2 hours agoWeiss Ratings Reiterates "Hold (C-)" Rating for Merck & Co., Inc. (NYSE:MRK)MarketBeatWeiss Ratings restated a "hold (c-)" rating on shares of Merck & Co., Inc. in a report on Saturday.NYSE:MRKRead Weiss Ratings Reiterates "Hold (C-)" Rating for Merck & Co., Inc. (NYSE:MRK)2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for Cytek Biosciences (NASDAQ:CTKB)MarketBeatWeiss Ratings reaffirmed a "sell (e+)" rating on shares of Cytek Biosciences in a research report on Friday.NASDAQ:CTKBRead Weiss Ratings Reiterates "Sell (E+)" Rating for Cytek Biosciences (NASDAQ:CTKB)2 hours agoWeiss Ratings Reiterates Buy (B-) Rating for CVR Partners (NYSE:UAN)MarketBeatWeiss Ratings reissued a "buy (b-)" rating on shares of CVR Partners in a report on Friday.NYSE:UANRead Weiss Ratings Reiterates Buy (B-) Rating for CVR Partners (NYSE:UAN)2 hours agoCVR Energy (NYSE:CVI) Given "Sell (D+)" Rating at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d+)" rating on shares of CVR Energy in a research note on Friday.NYSE:CVIRead CVR Energy (NYSE:CVI) Given "Sell (D+)" Rating at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Nebius Group (NBIS) to Release Earnings on Wednesday4Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why5Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened6Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade7HC Wainwright Has Positive Outlook of Plug Power Q3 Earnings8HCM II Acquisition (NASDAQ:HOND) Stock Price Down 10.9% - Here's What Happened All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoCustomers Bancorp's (CUBI) "Hold (C)" Rating Reiterated at Weiss RatingsMarketBeatNYSE:CUBIRead Customers Bancorp's (CUBI) "Hold (C)" Rating Reiterated at Weiss Ratings2 hours agoCustom Truck One Source (NYSE:CTOS) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNYSE:CTOSRead Custom Truck One Source (NYSE:CTOS) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Hold (C)" Rating for Cushman & Wakefield (NYSE:CWK)MarketBeatNYSE:CWKRead Weiss Ratings Reaffirms "Hold (C)" Rating for Cushman & Wakefield (NYSE:CWK)2 hours agoWeiss Ratings Reaffirms Buy (B) Rating for Curtiss-Wright (NYSE:CW)MarketBeatNYSE:CWRead Weiss Ratings Reaffirms Buy (B) Rating for Curtiss-Wright (NYSE:CW)2 hours agoCuriosityStream (NASDAQ:CURI) Given Hold (C) Rating at Weiss RatingsMarketBeatNASDAQ:CURIRead CuriosityStream (NASDAQ:CURI) Given Hold (C) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Hold (C-)" Rating for CureVac (NASDAQ:CVAC)MarketBeatNASDAQ:CVACRead Weiss Ratings Reaffirms "Hold (C-)" Rating for CureVac (NASDAQ:CVAC)2 hours agoCurbline Properties (NYSE:CURB) Rating Lowered to Sell (D+) at Weiss RatingsMarketBeatNYSE:CURBRead Curbline Properties (NYSE:CURB) Rating Lowered to Sell (D+) at Weiss Ratings2 hours agoCumberland Pharmaceuticals' (CPIX) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CPIXRead Cumberland Pharmaceuticals' (CPIX) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoCulp (NYSE:CULP) Given Sell (D-) Rating at Weiss RatingsMarketBeatNYSE:CULPRead Culp (NYSE:CULP) Given Sell (D-) Rating at Weiss Ratings2 hours agoCubeSmart (NYSE:CUBE) Given "Hold (C)" Rating at Weiss RatingsMarketBeatNYSE:CUBERead CubeSmart (NYSE:CUBE) Given "Hold (C)" Rating at Weiss Ratings2 hours agoCTS's (CTS) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:CTSRead CTS's (CTS) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D+)" Rating for CTO Realty Growth (NYSE:CTO)MarketBeatNYSE:CTORead Weiss Ratings Reaffirms "Sell (D+)" Rating for CTO Realty Growth (NYSE:CTO)2 hours agoCSP (NASDAQ:CSPI) Receives "Sell (D+)" Rating from Weiss RatingsMarketBeatNASDAQ:CSPIRead CSP (NASDAQ:CSPI) Receives "Sell (D+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Buy (B-) Rating for CSG Systems International (NASDAQ:CSGS)MarketBeatNASDAQ:CSGSRead Weiss Ratings Reiterates Buy (B-) Rating for CSG Systems International (NASDAQ:CSGS)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for CS Disco (NYSE:LAW)MarketBeatNYSE:LAWRead Weiss Ratings Reaffirms "Sell (D-)" Rating for CS Disco (NYSE:LAW)2 hours agoWeiss Ratings Reaffirms Sell (D+) Rating for CryoPort (NASDAQ:CYRX)MarketBeatNASDAQ:CYRXRead Weiss Ratings Reaffirms Sell (D+) Rating for CryoPort (NASDAQ:CYRX)2 hours agoCronos Group's (CRON) Sell (D+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CRONRead Cronos Group's (CRON) Sell (D+) Rating Reiterated at Weiss Ratings2 hours agoCrocs (NASDAQ:CROX) Cut to Sell (D+) at Weiss RatingsMarketBeatNASDAQ:CROXRead Crocs (NASDAQ:CROX) Cut to Sell (D+) at Weiss Ratings2 hours agoCriteo (NASDAQ:CRTO) Downgraded by Weiss Ratings to "Sell (D+)"MarketBeatNASDAQ:CRTORead Criteo (NASDAQ:CRTO) Downgraded by Weiss Ratings to "Sell (D+)"2 hours agoCRISPR Therapeutics (NASDAQ:CRSP) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:CRSPRead CRISPR Therapeutics (NASDAQ:CRSP) Receives Sell (D-) Rating from Weiss Ratings2 hours agoCrinetics Pharmaceuticals' (CRNX) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CRNXRead Crinetics Pharmaceuticals' (CRNX) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoCricut (NASDAQ:CRCT) Earns "Hold (C)" Rating from Weiss RatingsMarketBeatNASDAQ:CRCTRead Cricut (NASDAQ:CRCT) Earns "Hold (C)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B) Rating for CRH (NYSE:CRH)MarketBeatNYSE:CRHRead Weiss Ratings Reaffirms Buy (B) Rating for CRH (NYSE:CRH)2 hours agoWeiss Ratings Reiterates "Hold (C-)" Rating for Cresud S.A.C.I.F. y A. (NASDAQ:CRESY)MarketBeatNASDAQ:CRESYRead Weiss Ratings Reiterates "Hold (C-)" Rating for Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025If You Keep Cash In A U.S. Bank Account… Read This NOWFrom Banyan Hill Publishing (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025If You Keep Cash In A U.S. Bank Account… Read This NOWFrom Banyan Hill Publishing (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
